GGrantIndex
Sort

82,697 grants matching vaccine development

Mechanisms of broadly neutralizing humoral immunity against influenza viruses

$1,953,101
Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI

Nitric Oxide and Endothelial Function in Patients with Malaria

$1,952,659
Hans Ackerman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Bacteriophage-based approach for managing Shigella infections

$1,952,644
Alexander Sulakvelidze · Intralytix, Inc. · U01 · FY2020 · AI

Aging and Immunity to Infection

$1,952,103
Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2016 · AG

DNA Vaccines

$1,951,994
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)

$1,951,992
Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2024 · CA

HIV VACCINE TRIAL CLINICAL UNIT

$1,951,570
Harvard University (Medical School) · U01 · FY2005 · AI

Center for Biomedical Engineering Technology Acceleration (BETA Center)

$1,951,275
Manu Platt · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB

Prophylactic Anthrax Toxin Vaccine

$1,950,219
Vical, Inc. · R44 · FY2005 · AI

Development testing of nucleic acid-based vaccine for HIV other indications

$1,950,208
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease

$1,950,107
Cynthia Nau Cornelissen · Georgia State University · U19 · FY2019 · AI

Colorado Head and Neck Cancer SPORE

$1,950,049
Antonio Jimeno · University Of Colorado Denver · P50 · FY2025 · CA

SPORE in Cervical Cancer

$1,949,494
T.-C. Wu · Johns Hopkins University · P50 · FY2024 · CA

Project 2 - GMP Manufacturing of mRNA Immunogens

$1,949,407
Thomas N Denny · Duke University · U19 · FY2020 · AI

cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine

$1,949,201
Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2020 · AI

Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection

$1,948,930
Ananda W Goldrath · University Of California, San Diego · P01 · FY2021 · AI

Aging and Immunity to Infection

$1,948,923
Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2014 · AG

Protein homeostasis mechanisms underlying enterovirus replication and evolution

$1,948,790
Raul Andino · University Of California, San Francisco · P01 · FY2012 · AI

Live attenuated vaccines for epidemic and pandemic flu

$1,948,534
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI

Mosquito Immune Responses and Malaria Transmission

$1,948,277
Carolina Barillas-Mury · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Development of Membrane Anchored Cytokines as Novel Vaccine Adjuvants for the Elderly

$1,948,234
Christopher Pack · Metaclipse Therapeutics Corporation · N44 · FY2019 · AI

Flow Cytometry Core

$1,948,222
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI

University of Pittsburgh Clinical Trials Unit

$1,948,098
John W Mellors · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · AI

Mechanisms and Immunological Consequences of Host-Virus Interactions

$1,947,788
Ulrich H Von Andrian · Harvard Medical School · P01 · FY2015 · AI

Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development

$1,946,966
David I Watkins · University Of Miami School Of Medicine · P01 · FY2014 · AI